Pericardial Mesothelioma Treatment
Pericardial Mesothelioma is an extremely difficult cancer to treat and presently, all treatment methods used have a poor success rate. The chances of a patient’s survival depend largely on how early and how aggressively the cancer is treated. If pericardial mesothelioma is treated when it has fully matured and developed then the chances of survival are very slim and the prognosis for a patient could be only a couple of months. The latency period of pericardial mesothelioma (30 – 50 years), and its symptoms which are ordinary of other more common diseases such as pneumonia, make it extremely difficult to diagnose and therefore difficult to treat in its early stages. In this way, a lot of pericardial mesothelioma treatments do not aim to cure patients but instead focus on reducing the symptoms.
Before a patient is treated, a doctor will evaluate him or her, and afterwards decide which treatment method is most suitable for the patient’s situation. The patient’s age, medical history, general well being and even weight are taken into account before the doctor will decide which of the three treatments are most appropriate. These treatments are surgery, chemotherapy and radiation therapy.
Before a patient is treated, a doctor will evaluate him or her, and afterwards decide which treatment method is most suitable for the patient’s situation. The patient’s age, medical history, general well being and even weight are taken into account before the doctor will decide which of the three treatments are most appropriate. These treatments are surgery, chemotherapy and radiation therapy.